Reveal LINQ Insertable Cardiac Monitor vs Steth IO

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by STRATOSCIENTIFIC

AI Verdict

Tool A, the Reveal LINQ Insertable Cardiac Monitor, is an implantable device focused on long-term, continuous ECG monitoring for detecting infrequent cardiac arrhythmias. In contrast, Tool B, Steth IO, is a smartphone-powered digital stethoscope designed for real-time auscultation, visualization, and sharing of heart and lung sounds for immediate diagnostic aid and telemedicine. While both contribute to remote cardiac care and monitoring, they address different clinical needs with distinct technological approaches.

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose Reveal LINQ Insertable Cardiac Monitor if you require continuous, long-term, and highly accurate monitoring for patients with suspected infrequent cardiac arrhythmias or unexplained syncope. Its deep learning AI algorithms significantly reduce false alerts, ensuring a higher diagnostic yield over an extended period of up to 4.5 years.

View Reveal LINQ Insertable Cardiac Monitor →

Choose Steth IO if…

Choose Steth IO if you need a versatile, portable, and real-time digital stethoscope solution for both in-person and remote patient care. This smartphone-powered device allows immediate visualization, recording, and secure sharing of heart and lung sounds, making it ideal for telemedicine consultations and enhancing diagnostic accuracy on demand.

View Steth IO →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Reveal LINQ Insertable Cardiac Monitor Steth IO
Pricing Contact vendor Customized pricing; subscription-based for steth io spot.
Deployment Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator. Mobile app, Cloud-based system.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ Insertable Cardiac Monitor

For continuous, long-term monitoring, the 'set and forget' nature of an implanted device with automated data transmission offers superior patient usability compared to the active engagement required for each examination with a smartphone stethoscope. While Tool B offers interactive clinician features, Tool A's patient experience for its primary function is less intrusive and requires minimal ongoing effort.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

Tool A's deep learning AI directly addresses a critical challenge in long-term cardiac monitoring by significantly reducing false alerts, thereby improving diagnostic accuracy and efficiency for specific conditions like AF and syncope. While Tool B enhances traditional auscultation and telemedicine, Tool A's AI provides a more specialized and impactful clinical improvement for continuous rhythm analysis.

Pricing & Value

Steth IO

Steth IO provides at least some public pricing information for a component of its offering, offering a degree of transparency that Medtronic's Reveal LINQ ICM completely lacks. This partial transparency allows potential users to better estimate costs and value, even if full solution pricing still requires direct contact.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Medtronic's established reputation as a global medical device leader, coupled with explicit statements of HIPAA compliance and BAA availability, indicates a robust and proven infrastructure for enterprise deployment. Tool B's caveat regarding user responsibility for HIPAA compliance and a warning for email export suggests a less comprehensive or mature enterprise-level compliance framework from the vendor's side.

Innovation

Reveal LINQ Insertable Cardiac Monitor

While both tools demonstrate innovation, Tool A's application of deep learning AI to significantly reduce false positives in long-term, continuous cardiac monitoring represents a more advanced and impactful leap in diagnostic accuracy and efficiency for its specific clinical domain. The ability to filter out noise and provide more reliable data over extended periods is a substantial innovation in cardiac diagnostics.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

As a major global medical device manufacturer, Medtronic is expected to have extensive resources dedicated to customer support, comprehensive documentation, training programs, and a wide network of field service representatives. While STRATOSCIENTIFIC may offer personalized support, it is unlikely to match the breadth and depth of support infrastructure provided by a company of Medtronic's scale.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Reveal LINQ Insertable Cardiac Monitor Steth IO
Name Reveal LINQ Insertable Cardiac Monitor Steth IO
Company Medtronic STRATOSCIENTIFIC
Description The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope. Steth IO by STRATOSCIENTIFIC is an FDA-cleared smartphone stethoscope that transforms a mobile device into a powerful diagnostic aid. It enables healthcare providers to hear, visualize, record, and share heart and lung sounds in real-time, enhancing diagnostic accuracy and facilitating advanced telemedicine and remote patient monitoring for comprehensive patient care.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Pediatrics Cardiology, Internal Medicine, Pulmonology
Key Features AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting) Smartphone-powered stethoscope hardware and app, Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram), Record and save patient exams, Share exams with specialists/other healthcare providers, Digital filters for sound enhancement and ambient noise attenuation, Annotation tool for adding notes to exams, Telemedicine capabilities (live auscultation, video calls, scheduling), Remote patient monitoring

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ Insertable Cardiac Monitor and Steth IO.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Reveal LINQ ICM is an implantable device for continuous, long-term subcutaneous ECG monitoring, ideal for diagnosing conditions like atrial fibrillation and syncope over extended periods. Steth IO, a smartphone-powered stethoscope, integrates into real-time examinations, telemedicine, and remote patient monitoring by allowing immediate auscultation, visualization, recording, and sharing of heart and lung sounds.
The Reveal LINQ ICM utilizes AccuRhythmu2122 AI algorithms, which are designed to reduce false alerts for atrial fibrillation (AF) and pauses, thereby enhancing the diagnostic yield for these conditions. This deep learning AI aims to provide more accurate heart monitoring over the long term, with reported reductions of 88.2% in false AF alerts and 97.4% in false Pause alerts for LINQ IIu2122 ICM with AccuRhythmu2122 AI algorithms.
The provided information does not explicitly detail specific EHR integration capabilities for either the Reveal LINQ ICM or Steth IO. The Reveal LINQ ICM transmits data to the cloud-based CareLinku2122 network, while Steth IO is a mobile app and cloud-based system designed for secure data sharing.
For the Reveal LINQ ICM, the learning curve involves understanding the minimally invasive implant procedure, remote programming via the Reveal LINQu2122 Mobile Manager app, and interpreting enhanced ECG data from the CareLinku2122 network. Steth IO, being a smartphone-powered stethoscope, would involve learning to use the mobile app for real-time auscultation, visualization, recording, and sharing of sounds, potentially offering quicker adoption for immediate diagnostic aid.
For the Reveal LINQ ICM, multi-site rollout would involve standardizing implant procedures, managing remote programming across different clinics, and ensuring consistent patient education for the MyCareLink Heartu2122 app or MyCareLink Relayu2122 home communicator. For Steth IO, considerations would include distributing the smartphone stethoscope hardware, training staff on the mobile app and cloud system for real-time auscultation and telemedicine across various sites, and managing secure data sharing protocols, with its platform designed for scalability and one-click implementation for virtual clinics.
AI Tool Finder
AI-powered search. Results may not be comprehensive.